EUVIMED · CrossrefZeitschrift
Therapeutic Advances in Drug Safety
ISSN 2042-0986 · SAGE Publications
Neueste Artikel
Comparative ocular adverse events across immune checkpoint and targeted therapies in melanoma: A FAERS-based pharmacovigilance analysis
Goserelin-triggered immune-mediated rhabdomyolysis in a patient receiving long-term rosuvastatin therapy: A case report
Medication knowledge in psychiatric day hospital patients: The role of polypharmacy
Post-marketing safety signals and report-level ARIA-E stratification for lecanemab and donanemab: an integrated FAERS and WHO-VigiAccess pharmacovigilance study
Sex-specific risk factors for genital infections associated with SGLT2 inhibitors in type 2 diabetes: a retrospective cohort study and disproportionality analysis using JADER
Detection of clinically significant drug-drug interactions in serotonin syndrome: a multisource real-world data and pharmacovigilance study
Donor and recipient genetic polymorphisms modulate tacrolimus pharmacokinetics during voriconazole co-therapy: a drug–drug interaction study in liver transplant recipients
Disparities and trends in drug-related adverse reaction mortality in the United States, 1999–2020
How is AI developing in pharmacovigilance?
Can large language models detect drug–drug interactions leading to adverse drug reactions?
Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration
Cardiotoxicity associated with antineoplastic agents: a pharmacovigilance study based on FDA adverse event reporting system
Transformer-based models for ADR detection: cross-drug validation and benchmarking against large language models
Evaluating seizures associated with novel antineoplastic agents during breast cancer treatment using the Food and Drug Administration Adverse Event Reporting System and Canada Vigilance Adverse Reaction Online Database
A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging
Impact of dipeptidyl peptidase-4 inhibitors on incidence of colorectal cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Artificial intelligence in drug development: reshaping the therapeutic landscape
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021
Drug–drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different CYP3A5 genotypes
Olanzapine for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a randomized controlled trial
Safety profile of drugs used in non-cystic fibrosis bronchiectasis: a narrative review
Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Exploring the community pharmacist’s knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study
Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database
Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients
Flow rate accuracy of infusion devices within healthcare settings: a systematic review
Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature
Pharmacovigilance: reporting requirements throughout a product’s lifecycle
Definition of self-medication: a scoping review
EUVIMED